Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

5.3%

1 terminated/withdrawn out of 19 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

21%

4 trials in Phase 3/4

Results Transparency

87%

13 of 15 completed trials have results

Key Signals

1 recruiting13 with results

Enrollment Performance

Analytics

N/A

14(77.8%)

Phase 3

4(22.2%)

18Total

N/A(14)

Phase 3(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials

NCT02659215Not ApplicableActive Not Recruiting

HyaloFAST Trial for Repair of Articular Cartilage in the Knee

Role: lead

NCT06741527Not ApplicableRecruiting

Integrity Implant System Post Market Clinical Follow-Up Study

Role: lead

NCT06353893Active Not Recruiting

MRI Evaluation of Integrity Implant for Rotator Cuff Tears

Role: collaborator

NCT04204265Not ApplicableCompleted

MONOVISC for Shoulder Joint Pain Relief Due to Osteoarthritis

Role: lead

NCT04204083Not ApplicableCompleted

MONOVISC for Hip Joint Pain Relief Due to Osteoarthritis

Role: lead

NCT04204278Not ApplicableCompleted

MONOVISC for Ankle Joint Pain Relief Due to Osteoarthritis

Role: lead

NCT04640298Not ApplicableCompleted

Study of Cingal® for Symptomatic Relief of Osteoarthritis of Hip Joint

Role: lead

NCT04640974Not ApplicableCompleted

Study of Cingal® for Symptomatic Relief of Osteoarthritis of Ankle Joint

Role: lead

NCT04640961Not ApplicableCompleted

Study of Cingal® for Symptomatic Relief of Osteoarthritis of Shoulder Joint

Role: lead

NCT04084704Not ApplicableCompleted

A Prospective Evaluation of the Cingal Injection for Hip Osteoarthritis

Role: collaborator

NCT04231318Phase 3Completed

Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain

Role: lead

NCT00653432Not ApplicableCompleted

Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee

Role: lead

NCT01891396Not ApplicableCompleted

Cingal Study for Knee Osteoarthritis

Role: lead

NCT03390036Phase 3Completed

Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up

Role: lead

NCT02861183Not ApplicableWithdrawn

Study of Sodium Hyaluronate to Provide Symptomatic Relief of Lateral Epicondylosis (Tennis Elbow)

Role: lead

NCT02381652Phase 3Completed

Repeat Injection of Cingal® for Osteoarthritis of the Knee

Role: lead

NCT03191903Phase 3Completed

Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide

Role: lead

NCT04026191Not ApplicableCompleted

OVT for Epicondylosis (Tennis Elbow)

Role: lead

NCT01147172Not ApplicableCompleted

Safety Study of Cosmetic Tissue Augmentation in People of Color

Role: lead

All 19 trials loaded